PF-04447943
Drug timelines are a Plus or Pro feature.
7 regulatory and trial events tracked for PF-04447943, covering 2009-02-25 to 2020-11-19. Get the full timeline:
Most recent: Clinical Trial Update: A Study Of PF-04447943 Compared To Placebo In Subjects With Mild To Moderate Alzheimer's Disease [Phase 2]